Funding of sickle cell diseases because of Race.

Sickle cell disease is a disease that is most prevalent in people of African descent along with people of Mediterranean and Middle Eastern origin. This disease is known to affect about 70, 000 Americans and about 2 million people carry the trait (meaning that, they carry a single gene mutation).

Finally, advocates of race-based medicine claim that the scientific underpinnings are irrelevant if a medication is proven to be effective for a particular group. In such a way, race-based medicine is a short-term solution, treating the symptoms of race-related disease without understanding the

Although there is no biological basis for race, various ethnic groups have unique health problems associated with them. For example, sickle cell in African Americans, or Indians and hypertension. When talking about genetic difference, we straddle a fine line. With its history in racism in eugenics, it’s important to understand that these genetic differences don’t necessarily have anything to do with. As explained by Eric Kraut (2007), sickle cell is not a ‘black’ disease. The genes for sickle cell are present in Mediterranean, Middle Eastern, African, and Indian DNA. Due the the regions in which certain ethnicities have lived, small and normally inconsequential genetic traits can get expressed as illness. That’s nothing new. Huntington 's disease that affects a lot of people of European ancestry, but as Stephanie Liou (2012) explores, Huntingtons is also prevalent in the Japanese. These types of genetic differences aren’t racial, certain ethnic groups just have higher chances of expressing certain genes. Overall our genetic makeups are still almost the same. Here is where the health disparity lies. Not viewing these genetic differences actively hurts the health of minority groups. We need to look at the effects of genetic differences in health diversity, this is so much more important any rhetoric we discuss about race, it’s not just hurting people’s socio-economic status. When we fail to accept genetic

The pain from sickle cell disease most of the time is undertreated because the federal government wants doctors only to prescribe and to screen the patient to make sure that they are taking the medication and not selling them. The funding is much lower for sickle cell disease compared to other diseases like cystic fibrosis that affect Caucasians. The funding is 3.5 more for cystic fibrosis than for SCD. Cystic Fibrosis has more drug medication than SCD. Hispanics and African Americans generally receive under treatment because they do not receive pain medication or very little than what Caucasians do according to a

Sickle cell anemia (SCA) is an inherited disorder that produces sickle or crescent shape red blood cells. Thus, the mutated erythrocytes result in an inadequate supply of oxygen being transported throughout the body. Research shows that among those affected the most with the sickle cell gene are African Americans. In recent years, we have seen a decrease in mortality and morbidity rates as a result of new approaches to treating the disease. The more we understand the pathophysiology of sickle cell anemia, the more we learn about developing therapies for genetic disorders such as SCA. In this paper, we will briefly discuss what sickle cell anemia is and possible treatments for people with sickle cell anemia such as gene therapy and new drugs.

The past century has seen a significant increase in diversity across the United States. Approximately 36% of the population belongs to an ethnic or racial minority group according to the most recent census information. For the majority of the American population, infant mortality has been reduced and life expectancy has significantly increased. Health indicators such as these show improvement but minorities still continue to experience a disproportionate burden of death, disability, preventable disease, access to care, and treatment options. The disparities become even more pronounced when looking at awareness and treatment for particular diseases that are specific to a minority group. Sickle

The potential impact of writing the article, “Sickle Cell Anemia Pain Pathology” was to increase nurses’ knowledge of SCD and methods of treatments. According to Isokariari (2016), insufficient awareness and training of SCD exist in the medical community. An in-depth insight of the pathology of SCD among the health community positively affects the quality of health care provided to individuals living with SCD. Jenerette et al. (2015) state that nurses’ negative attitudes affect the patients with SCD outcomes. Negative attitudes toward the lifelong pain that patients with SCD encounter are often preconceived ideas developed prior to nursing school that requires addressing through increasing awareness of SCD (Jenerette et al., 2015). Patients

Sickle Cell anemia is associated with lifelong morbidity and reduced life expectancy.All infants are screened, with findings confirmed by hemoglobin electrophoresis, a complete blood count, reticulocyte count, and peripheral blood smear.Treatment goals include fluid replacement therapy, pain management, and symptom control. Sickle Cell anemia is prevalent among African American but also common in the Hispanic

Sickle cell disease (SCD) is an inherited and noncontagious, lifelong condition. More specifically, per Ohaeri, Shokunbi, Akinlade, & Dare, 1995, SCD is a generic term for a group of genetic disorders characterized by the predominance of sickle cell hemoglobin (Hgb). Hemoglobin is a protein in the red blood cells that carries oxygen throughout the body. The disease produces significantly abnormal Hgb molecules in red blood cells (RBCs). In sickle cell anemia, the red blood cells become rigid and sticky and are shaped like sickles or crescent moons. These irregularly shaped cells can get stuck in small blood vessels, which can slow or block blood flow and oxygen to parts of the body (Ohaeri, Shokunbi, Akinlade, & Dare, 1995, p. 955.Individuals

It is interesting to know the relationship between race and body structure, skin color, other visible characteristics, enzymatic and genetic variations, susceptibility to diseases and nutritional preferences varies among certain racial groups (Giger, 2013). There are marked intra individual and inter individual inconsistency in SCD. Medical heterogeneity of the disease has been clarified by both genetic and environmental factors. Identified genetic causes adding to differences in clinical severity of the disease include the pattern of sickle cell inheritance. Other modulators of the disease include environmental factors such as access to optimal health care, ambient living conditions, and availability of finance. Proper training of healthcare

The author’s connection to the article “Racial Bias in Medicine Leads to Worse Care for Minorities” is he personally witness these encounters. Schroder is very passionate covering an array of health-related issues from cancer to depression and prevention to overtreatment. Michael O. Schroeder intention for the text is present and discuss the occurrence of racial inequality among the health system. Throughout the article, displays the issue with personal stories, statically evidence and reputable researchers. The objective of the text is to target medical providers and society regarding this unspoken issue to reconsider the prejudice of racism. The author’s topic to the issue is the ethnic bias from Dr. Ron Wyatt perspective and treatment provided

The amount of people with cystic fibrosis is about a third of the people who have the sickle cell disease. There are over one hundred care centers for people with cystic fibrosis while there are only around ten for sickle cell disease patients. Older sickle cell patients have “limited access to medications” despite having many visits to the emergency room. Although racism is not the only factor of the “oversimplification” of sickle cell disease, it is clear that people put other genetic illnesses, such as cystic fibrosis, over sickle cell disease (Ellis 1-3).

Sickle Cell Disease is a genetic disease caused by a SNP (Single Nucleotide Polymorphism). Which means it is caused by a single letter gene mutation. Through the advent of CRISPR/Cas9 the disease might be cured. It is a serious reality and will enter medical trials within a handful of years. Sickle Cell Disease is an inherited disease that predominantly affects people of African descent. Red Blood cells become rigid and sickle shaped, causing blockages and pain crises. In cases of Sickle Cell Disease the Beta-Globin are mutated causing faulty and deformed Hemoglobin proteins thus creating sickled and short-lived Red Blood Cells.

Sickle cell anemia is an autosomal recessive point mutation that is often attributed to populations in Africa and the Middle East. This is due to a the high occurrence of malaria in these regions, however, the rate at which both sickle cell anemia and malaria are occurring in other regions of the globe is becoming increasingly prevalent. Immigration during the past few decades has resulted in what is now being considered an epidemic. The resources available to treat those with these diseases in more developed nations are abundant in comparison to places in Africa and the Middle East, yet regardless of treatment options, those who have sickle cell anemia still suffer greatly. How a society manages this illness is based on resources, treatment options, and funding. In some areas, sickle cell is more widespread than in others and the impact on the society yields a greater threat. In order to better understand the disease, one must start at the foundations and work upwards, following its progression and migration throughout the world.

consequently had more of a prevalence of SCD while they were compared to those who did not undergo a hemodialysis (Derebail et al, 2014). Concluding from this one study that dealt mainly with African-Americans, the results show how prevalent sickle-cell disease can be in black people. The higher rate of the trait can again be linked back to the monetary elements but it may not be limited only be limited to that as family ties are an important genetic factor of this disease.